A new injectable weight loss treatment from the maker of Ozempic and Wegovy delivered 23% weight loss in trials, according to findings published in the New England journal and medicine. Dr. Roshini ...

MacDonald and MacVicar, who were recognized during the recent athletic awards dinner, represented Charlottetown-based Colonel ...

Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an overreaction to GLP-1 news.

April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs ...

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions.

Eli Lilly and Novo Nordisk now offer the injectable drugs for $500 in most cases for patients who pay using their own money instead of going through insurance.

Eli Lilly's R&D portfolio includes 77 projects, 22 of which are in Phase 3. At the same time, Novo has 47 projects , three of which have been submitted to regulators for approval, and 12 are in ...

About Lilly Canada Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by ...

Since 2003, the Lilly Endowment has sold more than 50 million Eli Lilly and Co. shares, or about 30% of its holdings. But as of Dec. 31, Lilly shares accounted for 93% of the endowment’s wealth.

The new setups in Beijing will “further deepen Eli Lilly’s century-old business layout in China," Chief Scientific Officer and President of Lilly Research Laboratories Daniel Skovronsky, M.D ...

Founded by Colonel Eli Lilly in 1860, the pharmaceutical company develops, manufactures, and sells prescription drugs for humans and animals. Through the use of biotechnology, chemistry, and genetic ...